MLEC
Moolec Science SA Ordinary SharesNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$7.91M
P/E Ratio
—
EPS
$-242.41
Beta
-0.32
52W High
$157.05
52W Low
$3.08
50-Day MA
$8.97
200-Day MA
$22.43
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Moolec Science SA Ordinary Shares
Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company is headquartered in Luxembourg.
Fundamentals
| Revenue (TTM) | $7.83M |
| Gross Profit (TTM) | -639,496 |
| EBITDA | $-8.07M |
| Operating Margin | 0.00% |
| Return on Equity | -174.70% |
| Return on Assets | -21.70% |
| Revenue/Share (TTM) | $2.04 |
| Book Value | $0.70 |
| Price-to-Book | 1.07 |
| Price-to-Sales (TTM) | 0.01 |
| EV/Revenue | 0.728 |
| EV/EBITDA | -1.01 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 948.00% |
| Shares Outstanding | 726,120 |
| Float | 897,820 |
| % Insiders | 21.06% |
| % Institutions | 0.25% |
Data last updated: 4/8/2026